Rizatriptan Benzoate Tablet
Product Images NDC 71335-2031

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 71335-2031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352031)

This is a description of a medication named Rizatriptan Benzoate. It comes in a white capsule form with the label RZT;5. The tablet is available in a blister pack of Maxalt SM%. It is advisable to store this medication at room temperature, i.e., between 20°C- 25°C (68°F- 77°F). The manufacturer is Alkem Laboratories Limited. The medicine has an expiry date and comes in a package of 30 tablets. The NDC number is 7133520311 06613301523487.*

FDA Label Image

Rizatriptan-fig-1 (Rizatriptan Fig 1)

The text appears to be a chart showing the probability of response to a placebo and two doses of RIZATRIPTAN BENZOATE over a period of 10 hours post-dose. It is not possible to discern the context and purpose of this chart.*

FDA Label Image

Rizatriptan-fig-2 (Rizatriptan Fig 2)

FDA Label Image

Rizatriptan-fig-5 (Rizatriptan Fig 5)

FDA Label Image

Rizatriptan-structure (Rizatriptan Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.